Skip to main content
Research

Publications: Dr Sara Calder¿n

Calderón-Larrañaga S, Greenhalgh T, Clinch M, Robson J, Dostal I, Eto F, Finer S ( 2023 ) . Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation . BMC Medicine vol. 21 , ( 1 )
Rodríguez Benito L, Benedé Azagra CB, Cubillo Llanes J, Calderón Larrañaga S ( 2023 ) . Prescripción social y recomendación de activos en Atención Primaria: «el círculo de calidad» . Revista Clínica de Medicina de Familia
Antequera A, Cuadrado-Conde MA, Roy-Vallejo E, Montoya-Martínez M, León-García M, Madrid-Pascual O, Calderón-Larrañaga S ( 2022 ) . Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study . Systematic Reviews vol. 11 , ( 1 )
Calderón-Larrañaga S ( 2022 ) . How to make family medicine attractive to new graduates . FMC Formacion Medica Continuada en Atencion Primaria vol. 29 , ( 9 ) 473 - 475 .
Khalid S, Calderon-Larranaga S, Sami A, Hawley S, Judge A, Arden N, Van Staa TP, Cooper C et al. ( 2022 ) . Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database . Osteoporosis International vol. 33 , ( 7 ) 1579 - 1589 .
Calderón-Larrañaga S, Greenhalgh T, Finer S, Clinch M ( 2022 ) . What does the literature mean by social prescribing? A critical review using discourse analysis . Sociology of Health and Illness vol. 44 , ( 4-5 ) 848 - 868 .
Calderón-Larrañaga S, Milner Y, Clinch M, Greenhalgh T, Finer S ( 2021 ) . Tensions and opportunities in social prescribing. Developing a framework to facilitate its implementation and evaluation in primary care: a realist review . BJGP Open vol. 5 , ( 3 ) 1 - 13 .
Calderón-Larranãga S, Valls-Pérez B, Cardo-Miota A, Botello B, Lafuente N, Hernán M ( 2021 ) . Development and evaluation of a training programme on asset-based community development aimed at general practice trainees: Protocol for a mixed-method multilevel and multicentric action research study . BMJ Open vol. 11 , ( 5 )
Calderón Larrañaga S, Clinch M, Greenhalgh T, Finer S ( 2021 ) . Could social prescribing contribute to type 2 diabetes prevention in people at high risk? Protocol for a realist, multilevel, mixed methods review and evaluation . BMJ Open vol. 11 , ( 4 )
Calderón-Larrañaga S, Braddick F ( 2021 ) . From social prescribing to community referrals: What works, for whom, in what context and how? . FMC Formacion Medica Continuada en Atencion Primaria vol. 28 , ( 3 ) 3 - 11 .
Gopal DP, Calderón-Larrañaga S ( 2021 ) . Gut feeling is changing in the post-coronavirus world . British Journal of General Practice vol. 71 , ( 702 ) 24 - 24 .
Calderón Larrañaga S, Expósito Ruiz M, Cruz Vela P, Cuadrado Conde A, Alquézar Villarroya L, Garach Gómez A, Ruiz Hernández A, Toral López I ( 2019 ) . [Primary Care and oral health promotion: Assessment of an educational intervention in school children] . Aten Primaria vol. 51 , ( 7 ) 416 - 423 .
Valls Pérez B, Calderón Larrañaga S, March Cerdà JC, Oltra Rodríguez E ( 2018 ) . [Training in community health: challenges, threats and opportunities. SESPAS Report 2018] . Gac Sanit vol. 32 Suppl 1 , 82 - 85 .
Khalid S, Calderon-Larrañaga S, Hawley S, Ali MS, Judge A, Arden N, van Staa T, Cooper C et al. ( 2018 ) . Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database . Clin Epidemiol vol. 10 , 1417 - 1431 .
Calderón Larrañaga S, Rabanaque Hernández MJ ( 2014 ) . [Medical students and drug marketing] . Aten Primaria vol. 46 , ( 3 ) 156 - 166 .